A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology

In this video interview, our CMO, Dr. Andrew Hertler, talks with Dr. Jeffery Ward, an oncologist-hematologist with Swedish Cancer Institute, about the initial measures they implemented to protect patients, how they’re planning for the return of deferred care and procedures, and what the lasting impact of COVID-19 might be on the practice of oncology. 

 

 

Previous Article
Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping
Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping

Next Article
Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?
Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also nee...